Efficacy and safety of liraglutide in subjects with type 1 diabetes undergoing islet cell

Mise à jour : Il y a 4 ans
Référence : EUCTR2009-013090-18

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective is to investigate if treatment with liraglutide can increase the proportion of subjects who are insulin-independent one year after islet cell transplantation, and required only one (single-donor) islet cell transplant.


Critère d'inclusion

  • Diabetes Mellitus, Type 1